Financhill
Back

Verisk Analytics Vs. Axsome Therapeutics Industry Stock Comparison

Sell
49

VRSK
Verisk Analytics

Last Price:
$291.92
Seasonality Move:
5%
Sell
23

AXSM
Axsome Therapeutics

Last Price:
$96.71
Seasonality Move:
29%
Sell
49
Verisk Analytics (VRSK) is a Sell

Is Verisk Analytics a Buy, Sell or Hold?

  • The current Verisk Analytics [VRSK] share price is $285.78. The Score for VRSK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • VRSK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $95.65. The Score for AXSM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

  • The Verisk Analytics share price today is $285.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRSK is experiencing slight buying pressure.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $95.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.

VRSK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 46.03 Sell
Chaikin Money Flow: 289961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (284.18 - 297.26) Sell
Bollinger Bands (100): (278.97 - 294.75) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.16 Sell
Relative Strength Index (14 RSI): 27.75 Sell
Chaikin Money Flow: -108587 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106 - 126.46) Sell
Bollinger Bands (100): (90.82 - 121.54) Sell

VRSK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 289.83 Sell
20-day SMA: 290.2 Sell
50-day SMA: 291.76 Sell
200-day SMA: 278.88 Buy
8-day EMA: 287.71 Sell
20-day EMA: 290 Sell
50-day EMA: 289.55 Sell
200-day EMA: 276.97 Buy

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 102.69 Sell
20-day SMA: 114.92 Sell
50-day SMA: 118.82 Sell
200-day SMA: 96.67 Sell
8-day EMA: 102.96 Sell
20-day EMA: 110.86 Sell
50-day EMA: 113.08 Sell
200-day EMA: 99.41 Sell

Verisk Analytics Earnings Growth & VRSK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.34 per share, an increase this year of $1.79 per share, and an increase next year of $4.87 per share.

Verisk Analytics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):